Meeting
2018 ASCO Annual Meeting
Rhabdomyosarcoma in the first year of life. outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Authors
Monika Sparber-Sauer
Klinikum Stuttgart - Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pediatrics 5 (Oncology, Hematology, Immunology), Stuttgart, Germany
Monika Sparber-Sauer , Sabine Stegmaier , Christian Vokuhl , Ivo Leuschner , Guido Seitz , Thekla von Kalle , Monika Scheer , Marc W. Muenter , Stefan S. Bielack , Bernarda Kazanowska , Ruth Ladenstein , Felix Niggli , Gustaf Ljungman , Thomas Klingebiel , Joerg Fuchs , Simone Hettmer , Ewa Koscielniak
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Citation
J Clin Oncol 36, 2018 (suppl; abstr 10534)
DOI
10.1200/JCO.2018.36.15_suppl.10534
Abstract #
10534
Poster Bd #
207
Abstract Disclosures
Similar Posters
First Author: Annemiek Van Ommen - Nijhof
First Author: Bryan Kincheon Li
Poster
2017 ASCO Annual Meeting
Survival outcomes of the NeoALTTO study: Updated results of a randomized multicenter phase III neoadjuvant trial.
First Author: Jens Bodo Huober
Poster
2023 ASCO Annual Meeting
Breast cancer staging for patients with “low risk” disease: Are they all the same?
First Author: Jennifer Kay Plichta